Single intravenous dose of oritavancin for treatment of acute skin and skin structure infections caused by gram-positive bacteria: Summary of safety analysis from the phase 3 SOLO studies

  1. Corey, G.R.
  2. Loutit, J.
  3. Moeck, G.
  4. Wikler, M.
  5. Dudley, M.N.
  6. O'Riordan, W.
  7. Abete, J.F.
  8. Altmeyer, P.
  9. Basson, M.D.
  10. Bezrodnyi, B.G.
  11. Brennan, R.O.
  12. Bubnova, N.A.
  13. Chandra, A.
  14. Chandrasekharan, A.A.
  15. Chen, J.
  16. Condrea, C.
  17. Del Rayo Morfin, M.
  18. DeValle, O.
  19. Dunbar, L.
  20. Duttarroy, D.
  21. Giordano, P.
  22. Gonzalez, J.
  23. Gorgolas, M.
  24. Graham, D.R.
  25. Green, S.
  26. Gudz, I.
  27. Gupta, S.K.
  28. Heller, B.N.
  29. Hussein, O.
  30. Jauregui-Peredo, L.
  31. Kabler, H.
  32. Kazimir, M.
  33. Keech, R.C.
  34. Kelkar, D.
  35. Konychev, A.V.
  36. Koura, F.
  37. Kozlov, R.S.
  38. Laboranti, M.C.
  39. Lakhani, R.J.
  40. Lee, P.C.
  41. Leiman, D.
  42. Leiva, J.
  43. Lenskaya, L.G.
  44. Levchik, E.Y.
  45. Lombana-Martinez, C.
  46. Lucasti, C.
  47. Mahakalkar, C.C.
  48. Mannis, S.H.
  49. Manos, P.J.
  50. Marinescu, S.A.
  51. Mayakonda, R.K.
  52. McKinnell, J.
  53. Mehra, P.
  54. Minkowitz, H.
  55. Nagappa, Y.C.
  56. Nolan, P.
  57. Osiyemi, O.
  58. Overcash, J.S.
  59. Porwal, A.D.
  60. Pullman, J.
  61. Pyptiuk, O.
  62. Perez, N.Q.
  63. Rahav, G.
  64. Ramachandra, H.T.
  65. Reinhardt, J.
  66. Riesenberg, K.
  67. Rodoman, G.
  68. Romero-Cabello, R.
  69. Rozario, A.P.
  70. Shah, M.Y.A.S.
  71. Sandesc, D.
  72. Schlesinger, Y.
  73. Sears, W.K.
  74. Shapoval, S.D.
  75. Shulutko, A.
  76. Sims, M.
  77. Singh, R.
  78. Stenstrom, R.J.
  79. Tuckler, V.
  80. Voigt, D.
  81. Zaichuk, A.
  82. Zeltser, D.
  83. Zubareva, N.A.
  84. Show all authors +
Journal:
Antimicrobial Agents and Chemotherapy

ISSN: 1098-6596 0066-4804

Year of publication: 2018

Volume: 62

Issue: 4

Type: Article

DOI: 10.1128/AAC.01919-17 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals